Menu
Logo

Uptravi risk reduction

REFERENCE

1. Sitbon O, Channick R, Chin KM, et al; for the GRIPHON Investigators. Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med. 2015; 373(26):2522-2533.

CP-264074